In the high-risk population of PCI patients with polyvascular disease, the presence of diabetes represents a profoundly significant additional risk factor at long-term follow-up, associated with significantly higher adverse event risks – most evident in insulin-treated patients. Here, INS is linked to diabetes mellitus.